Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas
T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and...
Saved in:
Published in | International journal of hematology Vol. 107; no. 4; pp. 413 - 419 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Tokyo
Springer Japan
01.04.2018
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research. |
---|---|
AbstractList | T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research.T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research. T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research. T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research. |
Author | Chan, Jason Yongsheng Lim, Soon Thye |
Author_xml | – sequence: 1 givenname: Jason Yongsheng surname: Chan fullname: Chan, Jason Yongsheng organization: Division of Medical Oncology, National Cancer Centre Singapore, Cancer Science Institute of Singapore, National University of Singapore, SingHealth Duke-NUS Blood Cancer Centre – sequence: 2 givenname: Soon Thye surname: Lim fullname: Lim, Soon Thye email: lim.soon.thye@singhealth.com.sg organization: Division of Medical Oncology, National Cancer Centre Singapore, Office of Education, Duke-NUS Medical School, SingHealth Duke-NUS Blood Cancer Centre |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29380182$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1OGzEUha0KVAL0AbpBlrrpxsX2ePzTHYpaqIjCgnRtefwDg2bsYM8g5e07IWlVRYLV3Xyf77k-p-AopugB-EzwN4KxuCyEElkjTCSiDHPEP4AZkbxGlRDsCMywojWqBcEn4LSUJ4yJwEx8BCdUVXKy6AyslunFdzC00bXxocCQUw-HRw-vSmsiXGz69WPqDbwfRreB1zmN6-8wJDsWmCJcQRMdXN4i67sOdnu4nIPjYLriP-3nGfj988dqfoMWd9e_5lcLZFmlBkQFc17YhkuvHPe1JcTVIRhBWENl1WBGp0Nsw1jgjZJMCkW5C0Y6RhizojoDX3fvrnN6Hn0ZdN-WbRQTfRqLJkpVGHMl-IR-OUCf0pjjlO6VqgWthZyoiz01Nr13ep3b3uSN_vtfE0B2gM2plOzDP4Rgve1E7zrRE623nejtanHg2HYwQ5vikE3bvWvSnVmmLfHB5_9Cvyn9AdYEnWE |
CitedBy_id | crossref_primary_10_1038_s41467_019_12032_9 crossref_primary_10_1038_s41598_019_51522_0 crossref_primary_10_1007_s12149_021_01598_4 crossref_primary_10_3390_life11080838 crossref_primary_10_5045_br_2021_2020328 crossref_primary_10_1182_bloodadvances_2020001782 crossref_primary_10_3389_fimmu_2023_1068662 crossref_primary_10_3389_fonc_2022_796738 |
Cites_doi | 10.1200/JCO.2009.23.8592 10.1182/blood-2012-05-431460 10.3109/0284186X.2010.516272 10.1016/S1470-2045(13)70450-9 10.1016/S1470-2045(09)70265-7 10.1038/leu.2013.41 10.1016/S1470-2045(15)00533-1 10.1200/JCO.2012.45.6541 10.1038/bmt.2014.65 10.1182/blood-2016-12-756841 10.1158/1078-0432.CCR-12-1064 10.1186/1756-8722-6-86 10.1186/s13045-017-0452-9 10.3109/10428194.2011.569038 10.1155/2011/790871 10.1038/ng.3358 10.1038/leu.2016.13 10.1200/JCO.2009.23.8295 10.1182/blood-2013-11-536359 10.1007/s10637-012-9889-4 10.1200/JCO.2005.04.1384 10.1016/S1470-2045(16)30148-6 10.3960/jslrt.17018 10.1056/NEJMc1605684 10.1097/PAS.0b013e318222dfcd 10.18632/oncotarget.3776 10.1016/j.bbmt.2015.05.003 10.1038/leu.2015.44 10.7150/ijbs.7.1122 10.1002/ajh.23213 10.1038/leu.2010.295 10.1007/s10637-015-0258-y 10.1097/PAS.0000000000000312 10.1200/JCO.2011.35.6287 10.5045/br.2015.50.4.254 10.1182/blood-2008-10-185256 10.1200/JCO.2011.40.7098 10.1016/S2352-3026(15)00002-2 10.1158/2159-8290.CD-12-0028 10.1093/annonc/mdx684 10.1182/blood.V128.22.4128.4128 10.1200/JCO.2017.35.15_suppl.7549 10.3324/haematol.2017.180430 |
ContentType | Journal Article |
Copyright | The Japanese Society of Hematology 2018 International Journal of Hematology is a copyright of Springer, (2018). All Rights Reserved. |
Copyright_xml | – notice: The Japanese Society of Hematology 2018 – notice: International Journal of Hematology is a copyright of Springer, (2018). All Rights Reserved. |
DBID | AAYXX CITATION NPM 3V. 7RV 7T5 7T7 7TM 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA BENPR C1K CCPQU FR3 FYUFA GHDGH H94 K9. KB0 M0S M1P NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 |
DOI | 10.1007/s12185-018-2406-6 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed Technology Research Database ProQuest One Academic Middle East (New) Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed Technology Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1865-3774 |
EndPage | 419 |
ExternalDocumentID | 29380182 10_1007_s12185_018_2406_6 |
Genre | Journal Article Review |
GroupedDBID | --- --K -5E -5G -BR -EM -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 1B1 1N0 203 29J 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3V. 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6NX 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACDTI ACGFO ACGFS ACHSB ACHVE ACHXU ACIHN ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFKRA AFLOW AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BENPR BGNMA BKEYQ BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG EX3 F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HG5 HG6 HLICF HMCUK HMJXF HRMNR HZ~ IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IZQ I~X I~Z J-C J0Z JBSCW JZLTJ KOV KPH LLZTM M1P M41 M4Y MA- N9A NAPCQ NPVJJ NQ- NQJWS NU0 O9- O93 O9I O9J P2P P9S PF0 PQQKQ PROAC PSQYO PT4 Q2X QOR QOS R89 R9I RIG ROL RPX RPZ RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UDS UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WJK WK8 WOW X7M YLTOR Z45 Z7U Z81 Z82 Z87 ZMTXR ZOVNA ZXP AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ NPM PJZUB PPXIY 7T5 7T7 7TM 7XB 8FD 8FK C1K FR3 H94 K9. P64 PKEHL PQEST PQUKI 7X8 |
ID | FETCH-LOGICAL-c439t-274de7cb68e9d6e5c11d5ffa714b283b042377cb44f6b98487926dfa8d4144c73 |
IEDL.DBID | 7X7 |
ISSN | 0925-5710 1865-3774 |
IngestDate | Fri Jul 11 07:02:39 EDT 2025 Sat Jul 26 02:18:05 EDT 2025 Mon Jul 21 06:06:01 EDT 2025 Tue Jul 01 03:47:55 EDT 2025 Thu Apr 24 23:12:17 EDT 2025 Fri Feb 21 02:31:24 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Enteropathy-associated T-cell lymphoma NK/T-cell lymphoma JAK-STAT pathway Epstein–Barr virus |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c439t-274de7cb68e9d6e5c11d5ffa714b283b042377cb44f6b98487926dfa8d4144c73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Literature Review-3 ObjectType-Review-3 content type line 23 |
OpenAccessLink | https://link.springer.com/content/pdf/10.1007%2Fs12185-018-2406-6.pdf |
PMID | 29380182 |
PQID | 1993572578 |
PQPubID | 55446 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1993006976 proquest_journals_1993572578 pubmed_primary_29380182 crossref_primary_10_1007_s12185_018_2406_6 crossref_citationtrail_10_1007_s12185_018_2406_6 springer_journals_10_1007_s12185_018_2406_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20180400 2018-4-00 2018-Apr 20180401 |
PublicationDateYYYYMMDD | 2018-04-01 |
PublicationDate_xml | – month: 4 year: 2018 text: 20180400 |
PublicationDecade | 2010 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | International journal of hematology |
PublicationTitleAbbrev | Int J Hematol |
PublicationTitleAlternate | Int J Hematol |
PublicationYear | 2018 |
Publisher | Springer Japan Springer Nature B.V |
Publisher_xml | – name: Springer Japan – name: Springer Nature B.V |
References | Kwong, Anderson, Advani, Kim, Levine, Lim (CR1) 2009; 10 Chan (CR22) 2011; 7 Yang, Zhang, Zhu, Cao, Yuan, Xu, Wu, Wang, Wu, Lu, Zhu, Qian, Zhang, Hou, Liu, Li (CR27) 2015; 29 Venkatakrishnan, Kim, Lin, Thye, Chng, Ma, Chen, Zhou, Liu, Kelly, Kim (CR23) 2015; 33 Ito, Kimura, Maeda, Hashimoto, Ishida, Izutsu, Fukushima, Isobe, Takizawa, Hasegawa, Kobayashi, Okamura, Kobayashi, Yamaguchi, Suzumiya, Hyo, Nakamura, Kawa, Oshimi, Suzuki (CR29) 2012; 18 Jiang, Gu, Yan, Zhao, Xie, Zhang, Pan, Hu, Cai, Dong, Huang, Wang, Shen, Meng, Zhou, Hu, Wang, Liu, Yang, Zhang, Wang, Wang, Peng, Chen, Sun, Ding, Shi, Hou, Yan, Shi, Xu, Li, Lu, Zheng, Xue, Zhao, Chen, Chen (CR33) 2015; 47 Kim, Yoon, Jaccard, Chng, Lim, Hong, Park, Chang, Maeda, Ishida, Shin, Kim, Jeong, Yang, Jo, Lee, Choi, Lee, Chen, Kim, Jung, Murayama, Oki, Advani, d’Amore, Schmitz, Suh, Suzuki, Kwong, Lin, Kim (CR28) 2016; 17 Tan, Chuang, Tang, Tan, Ko, Chuah, Ng, Chng, Gatter, Loong, Liu, Hosking, Cheah, Teh, Tay, Koh, Lim (CR40) 2013; 27 Li, Xia, Feng, Chen, Li, Cui, Cai, Sim, Nairismägi, Laurensia, Meah, Liu, Guo, Chen, Feng, Pang, Chen, Chew, Ebstein, Foo, Liu, Ha, Khoo, Chin, Zeng, Aung, Chowbay, Diong, Zhang, Liu, Tang, Tao, Quek, Mohamad, Tan, Teh, Ng, Chng, Ong, Okada, Raychaudhuri, Lim, Tan, Peng, Khor, Bei (CR32) 2016; 17 Suzuki, Kwong, Maeda, Sakai, Kim, Suh, Ishida, Izutsu, Isobe, Maeda, Sueoka, Okoshi, Takizawa, Kobayashi, Nakamura, Suzumiya, Oshimi, Yamaguchi (CR14) 2015; 33 Au, Weisenburger, Intragumtornchai, Nakamura, Kim, Sng, Vose, Armitage, Liang (CR3) 2009; 113 Tse, Kwong (CR7) 2017; 10 Kwong, Chan, Tan, Kim, Poon, Mow, Khong, Loong, Au-Yeung, Iqbal, Phipps, Tse (CR19) 2017; 129 Kim, Moon, Moon, Park, Byeon, Kim (CR24) 2015; 50 Ahn, Kim, Hwang, Ko, Tang, Lim, Kim (CR21) 2013; 31 Iqbal, Wright, Wang, Rosenwald, Gascoyne, Weisenburger, Greiner, Smith, Guo, Wilcox, Teh, Lim, Tan, Rimsza, Jaffe, Campo, Martinez, Delabie, Braziel, Cook, Tubbs, Ott, Geissinger, Gaulard, Piccaluga, Pileri, Au, Nakamura, Seto, Berger, de Leval, Connors, Armitage, Vose, Chan, Staudt (CR42) 2014; 123 Kwong, Kim, Lim, Kim, Tang, Tse, Leung, Chim (CR12) 2012; 120 Hwang, Koh, Lim, Linn, Loh, Koh, Diong, Lee, Zhang, Rajgor, Gandhi, Shah, Goh (CR16) 2011; 52 Lee, Suh, Park, Ko, Bang, Lee, Lee, Huh, Oh, Kwon, Kim, Lee, Kim, Park, Oh, Kim, Jung, Park, Kim (CR26) 2006; 24 Kim, Choi, Hyun, Ki, Oh, Ahn, Ko, Choi, Jung, Khong, Tang, Yan, Lim, Kwong, Kim (CR30) 2015; 2 Lee, Park, Kang, Kim, Hwang, Lee, Kwak, Park, Yoo, Kim, Kim, Ko (CR35) 2015; 6 Chan, Chan, Cheuk, Wan, Lee, Lui, Chan (CR38) 2011; 35 Nairismägi, Pang, Huang, Tan, Lim, Li, Ha, Laurensia, Wijaya, Ng, Santoso, Teh, Tan, Lim, Ong (CR44) 2016; 128 Tan, Ooi, Ang, Koh, Wong, Dykema, Ngeow, Loong, Gatter, Tan, Lim, Furge, Tao, Lim, Loong, Cheah, Teh (CR39) 2011; 25 Tan, Tan, Lim, Kim, Kim, Advani, Kwong (CR2) 2013; 14 Takata, Hong, Sitthinamsuwan, Loong, Tan, Liau, Hsieh, Ng, Yang, Pongpruttipan, Sukpanichnant, Kwong, Hyeh Ko, Cho, Chng, Matsushita, Yoshino, Chuang (CR5) 2015; 39 Hari, Raj, Olteanu (CR25) 2016; 375 Koo, Tan, Tang, Poon, Allen, Tan, Chong, Ong, Tay, Tao, Quek, Loong, Yeoh, Yap, Lee, Lim, Tan, Goh, Cutcutache, Yu, Ng, Rajasegaran, Heng, Gan, Ong, Rozen, Tan, Teh, Lim (CR34) 2012; 2 Lim, Song, Lim, Laurensia, Pang, Nagarajan, Wijaya, Tan, Tang, Nairismägi, Ong (CR36) 2017; 35 Yamaguchi, Tobinai, Oguchi, Ishizuka, Kobayashi, Isobe, Ishizawa, Maseki, Itoh, Usui, Wasada, Kinoshita, Ohshima, Matsuno, Terauchi, Nawano, Ishikura, Kagami, Hotta, Oshimi (CR8) 2009; 27 Ng, Chung, Kato, Nakamura, Takahashi, Ko, Khoury, Yin, Soong, Jeyasekharan, Hoppe, Selvarajan, Tan, Lim, Ong, Nairismägi, Maheshwari, Choo, Fan, Lee, Chuang, Chng (CR43) 2017 Kim, Jung, Chuang, Hong, Guo, Cao, Hong, Suzuki, Kang, Won, Chng, Kwong, Suh, Song, Zhu, Tay, Lim, Suzumiya, Lin, Kim (CR4) 2013; 16 Farid, Yau, Tay, Quek, Tao, Koo, Loong, Lim (CR20) 2011; 50 Yhim, Kim, Mun, Moon, Chae, Park, Jo, Kim, Yoon, Cheong, Kwak, Lee, Kim, Suh, Yang (CR18) 2015; 21 Tse, Chan, Koh, Chng, Kim, Tang, Lim, Lie, Kwong (CR17) 2014; 49 Tse, Gill, Loong, Kim, Ng, Tang, Ko, Chng, Lim, Kim, Kwong (CR37) 2012; 87 Kwong, Kim, Tse, Oh, Kwak, Eom, Do, Mun, Lee, Shin, Suh, Chuang, Lee, Lim, Izutsu, Suzuki, Relander, d’Amore, Schmitz, Jaccard, Kim (CR13) 2017 Kim, Kim, Kim, Kim, Suh, Huh, Lee, Kim, Cho, Lee, Kang, Eom, Pyo, Ahn, Ko, Kim (CR10) 2009; 27 Schmitt, Sako, Bagot, Huang, Gaulard, Bensussan (CR31) 2011; 2011 Yamaguchi, Miyazaki (CR6) 2017; 57 Yamaguchi, Tobinai, Oguchi, Ishizuka, Kobayashi, Isobe, Ishizawa, Maseki, Itoh, Usui, Wasada, Kinoshita, Hotta, Tsukasaki, Oshimi (CR9) 2012; 30 Chan, Tang, Ng, Shih, Tay, Tao, Quek, Lim (CR15) 2012; 30 Yamaguchi, Kwong, Kim, Maeda, Hashimoto, Suh, Izutsu, Ishida, Isobe, Sueoka, Suzumiya, Kodama, Kimura, Hyo, Nakamura, Oshimi, Suzuki (CR11) 2011; 29 Nairismägi, Tan, Lim, Nagarajan, Ng, Rajasegaran, Huang, Lim, Laurensia, Wijaya, Li, Cutcutache, Pang, Thangaraju, Ha, Khoo, Chin, Dey, Poore, Tan, Koh, Sabai, Rao, Chuah, Ho, Ng, Chuang, Zhang, Liu, Pongpruttipan, Ko, Cheah, Karim, Chng, Tang, Tao, Tay, Farid, Quek, Rozen, Tan, Teh, Lim, Tan, Ong (CR41) 2016; 30 M Yamaguchi (2406_CR6) 2017; 57 E Tse (2406_CR17) 2014; 49 S Lee (2406_CR35) 2015; 6 K Takata (2406_CR5) 2015; 39 ML Nairismägi (2406_CR41) 2016; 30 L Jiang (2406_CR33) 2015; 47 SY Tan (2406_CR39) 2011; 25 M Yamaguchi (2406_CR9) 2012; 30 ML Nairismägi (2406_CR44) 2016; 128 GC Koo (2406_CR34) 2012; 2 YL Kwong (2406_CR12) 2012; 120 HK Kim (2406_CR24) 2015; 50 A Chan (2406_CR15) 2012; 30 WY Au (2406_CR3) 2009; 113 C Schmitt (2406_CR31) 2011; 2011 SJ Kim (2406_CR10) 2009; 27 K Venkatakrishnan (2406_CR23) 2015; 33 E Tse (2406_CR7) 2017; 10 M Yamaguchi (2406_CR11) 2011; 29 JY Chan (2406_CR22) 2011; 7 SJ Kim (2406_CR28) 2016; 17 P Hari (2406_CR25) 2016; 375 R Suzuki (2406_CR14) 2015; 33 JK Chan (2406_CR38) 2011; 35 M Farid (2406_CR20) 2011; 50 Y Ito (2406_CR29) 2012; 18 SB Ng (2406_CR43) 2017 J Lee (2406_CR26) 2006; 24 Y Yang (2406_CR27) 2015; 29 Z Li (2406_CR32) 2016; 17 SJ Kim (2406_CR30) 2015; 2 ST Lim (2406_CR36) 2017; 35 YL Kwong (2406_CR1) 2009; 10 D Tan (2406_CR2) 2013; 14 SY Tan (2406_CR40) 2013; 27 SJ Kim (2406_CR4) 2013; 16 WY Hwang (2406_CR16) 2011; 52 E Tse (2406_CR37) 2012; 87 YL Kwong (2406_CR19) 2017; 129 HK Ahn (2406_CR21) 2013; 31 HY Yhim (2406_CR18) 2015; 21 J Iqbal (2406_CR42) 2014; 123 M Yamaguchi (2406_CR8) 2009; 27 YL Kwong (2406_CR13) 2017 |
References_xml | – volume: 27 start-page: 6027 issue: 35 year: 2009 end-page: 6032 ident: CR10 article-title: Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study publication-title: J Clin Oncol doi: 10.1200/JCO.2009.23.8592 – volume: 120 start-page: 2973 issue: 15 year: 2012 end-page: 2980 ident: CR12 article-title: SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group publication-title: Blood doi: 10.1182/blood-2012-05-431460 – volume: 50 start-page: 589 issue: 4 year: 2011 end-page: 590 ident: CR20 article-title: A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma publication-title: Acta Oncol doi: 10.3109/0284186X.2010.516272 – volume: 14 start-page: e548 issue: 12 year: 2013 end-page: e561 ident: CR2 article-title: Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines publication-title: Lancet Oncol doi: 10.1016/S1470-2045(13)70450-9 – volume: 10 start-page: 1093 issue: 11 year: 2009 end-page: 1101 ident: CR1 article-title: Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(09)70265-7 – volume: 27 start-page: 1688 issue: 8 year: 2013 end-page: 1696 ident: CR40 article-title: Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype publication-title: Leukemia doi: 10.1038/leu.2013.41 – volume: 33 start-page: 140 issue: S1 year: 2015 ident: CR14 article-title: 5-year follow-up of the SMILE phase II study for newly-diagnosed stage IV, relapsed or refractory extranodal NK/T-cell lymphoma, nasal type publication-title: Hematol Oncol – volume: 17 start-page: 389 issue: 3 year: 2016 end-page: 400 ident: CR28 article-title: A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis publication-title: Lancet Oncol doi: 10.1016/S1470-2045(15)00533-1 – volume: 30 start-page: 4044 issue: 32 year: 2012 end-page: 4046 ident: CR9 article-title: Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211 publication-title: J Clin Oncol doi: 10.1200/JCO.2012.45.6541 – volume: 49 start-page: 902 issue: 7 year: 2014 end-page: 906 ident: CR17 article-title: Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group publication-title: Bone Marrow Transplant doi: 10.1038/bmt.2014.65 – volume: 129 start-page: 2437 issue: 17 year: 2017 end-page: 2442 ident: CR19 article-title: PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing -asparaginase publication-title: Blood doi: 10.1182/blood-2016-12-756841 – volume: 18 start-page: 4183 issue: 15 year: 2012 end-page: 4190 ident: CR29 article-title: Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-1064 – volume: 16 start-page: 86 issue: 6 year: 2013 ident: CR4 article-title: Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group publication-title: J Hematol Oncol doi: 10.1186/1756-8722-6-86 – volume: 10 start-page: 85 issue: 1 year: 2017 ident: CR7 article-title: The diagnosis and management of NK/T-cell lymphomas publication-title: J Hematol Oncol doi: 10.1186/s13045-017-0452-9 – year: 2017 ident: CR13 article-title: Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma publication-title: Ann Oncol – year: 2017 ident: CR43 article-title: EBV-associated primary nodal T/NK-cell lymphoma shows distinct molecular signature and copy number changes publication-title: Haematologica – volume: 52 start-page: 1382 issue: 7 year: 2011 end-page: 1386 ident: CR16 article-title: Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma publication-title: Leuk Lymphoma doi: 10.3109/10428194.2011.569038 – volume: 2011 start-page: 790871 year: 2011 ident: CR31 article-title: Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets publication-title: J Biomed Biotechnol doi: 10.1155/2011/790871 – volume: 47 start-page: 1061 issue: 9 year: 2015 end-page: 1066 ident: CR33 article-title: Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma publication-title: Nat Genet doi: 10.1038/ng.3358 – volume: 30 start-page: 1311 issue: 6 year: 2016 end-page: 1319 ident: CR41 article-title: JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma publication-title: Leukemia doi: 10.1038/leu.2016.13 – volume: 35 start-page: 7549 issue: 15 suppl year: 2017 ident: CR36 article-title: Oncogenic activation of STAT3 pathway drives PD-L1 expression in natural killer/T cell lymphoma publication-title: J Clin Oncol – volume: 27 start-page: 5594 issue: 33 year: 2009 end-page: 5600 ident: CR8 article-title: Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.23.8295 – volume: 123 start-page: 2915 issue: 19 year: 2014 end-page: 2923 ident: CR42 article-title: Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma publication-title: Blood doi: 10.1182/blood-2013-11-536359 – volume: 31 start-page: 469 issue: 2 year: 2013 end-page: 472 ident: CR21 article-title: Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma publication-title: Investig New Drugs doi: 10.1007/s10637-012-9889-4 – volume: 24 start-page: 612 issue: 4 year: 2006 end-page: 618 ident: CR26 article-title: Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study publication-title: J Clin Oncol doi: 10.1200/JCO.2005.04.1384 – volume: 17 start-page: 1240 issue: 9 year: 2016 end-page: 1247 ident: CR32 article-title: Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study publication-title: Lancet Oncol doi: 10.1016/S1470-2045(16)30148-6 – volume: 57 start-page: 98 year: 2017 end-page: 108 ident: CR6 article-title: Current treatment approaches for NK/T-cell lymphoma publication-title: J Clin Exp Hematop doi: 10.3960/jslrt.17018 – volume: 375 start-page: 1501 issue: 15 year: 2016 end-page: 1502 ident: CR25 article-title: Targeting CD38 in refractory extranodal natural killer cell-T-cell lymphoma publication-title: N Engl J Med doi: 10.1056/NEJMc1605684 – volume: 35 start-page: 1557 issue: 10 year: 2011 end-page: 1569 ident: CR38 article-title: Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression publication-title: Am J Surg Pathol doi: 10.1097/PAS.0b013e318222dfcd – volume: 6 start-page: 17764 issue: 19 year: 2015 end-page: 17776 ident: CR35 article-title: Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type publication-title: Oncotarget doi: 10.18632/oncotarget.3776 – volume: 21 start-page: 1597 issue: 9 year: 2015 end-page: 1604 ident: CR18 article-title: Consortium for improving survival of lymphoma study. Clinical outcomes and prognostic factors of up-front autologous stem cell transplantation in patients with extranodal natural killer/T cell lymphoma publication-title: Biol Blood Marrow Transplant doi: 10.1016/j.bbmt.2015.05.003 – volume: 128 start-page: 4128 year: 2016 ident: CR44 article-title: Generation of non-Hodgkin lymphoma patient-derived xenografts and in depth characterization of a monomorphic epitheliotropic intestinal T-cell lymphoma model publication-title: Blood – volume: 29 start-page: 1571 issue: 7 year: 2015 end-page: 1577 ident: CR27 article-title: Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study publication-title: Leukemia doi: 10.1038/leu.2015.44 – volume: 7 start-page: 1122 issue: 8 year: 2011 end-page: 1144 ident: CR22 article-title: A clinical overview of centrosome amplification in human cancers publication-title: Int J Biol Sci doi: 10.7150/ijbs.7.1122 – volume: 87 start-page: 663 issue: 7 year: 2012 end-page: 668 ident: CR37 article-title: Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group publication-title: Am J Hematol doi: 10.1002/ajh.23213 – volume: 25 start-page: 555 issue: 3 year: 2011 end-page: 557 ident: CR39 article-title: Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma publication-title: Leukemia doi: 10.1038/leu.2010.295 – volume: 33 start-page: 942 issue: 4 year: 2015 end-page: 953 ident: CR23 article-title: Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose publication-title: Investig New Drugs doi: 10.1007/s10637-015-0258-y – volume: 39 start-page: 1 issue: 1 year: 2015 end-page: 12 ident: CR5 article-title: Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia publication-title: Am J Surg Pathol doi: 10.1097/PAS.0000000000000312 – volume: 29 start-page: 4410 issue: 33 year: 2011 end-page: 4416 ident: CR11 article-title: Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study publication-title: J Clin Oncol doi: 10.1200/JCO.2011.35.6287 – volume: 50 start-page: 254 issue: 4 year: 2015 end-page: 256 ident: CR24 article-title: Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin publication-title: Blood Res doi: 10.5045/br.2015.50.4.254 – volume: 113 start-page: 3931 issue: 17 year: 2009 end-page: 3937 ident: CR3 article-title: Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project publication-title: Blood doi: 10.1182/blood-2008-10-185256 – volume: 30 start-page: 1015 issue: 9 year: 2012 end-page: 1016 ident: CR15 article-title: To SMILE or not: supportive care matters publication-title: J Clin Oncol doi: 10.1200/JCO.2011.40.7098 – volume: 2 start-page: e66 issue: 2 year: 2015 end-page: e74 ident: CR30 article-title: Risk stratification on the basis of Deauville score on PET–CT and the presence of Epstein–Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis publication-title: Lancet Haematol. doi: 10.1016/S2352-3026(15)00002-2 – volume: 2 start-page: 591 issue: 7 year: 2012 end-page: 597 ident: CR34 article-title: Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-12-0028 – volume: 17 start-page: 389 issue: 3 year: 2016 ident: 2406_CR28 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(15)00533-1 – volume: 6 start-page: 17764 issue: 19 year: 2015 ident: 2406_CR35 publication-title: Oncotarget doi: 10.18632/oncotarget.3776 – volume: 14 start-page: e548 issue: 12 year: 2013 ident: 2406_CR2 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(13)70450-9 – volume: 375 start-page: 1501 issue: 15 year: 2016 ident: 2406_CR25 publication-title: N Engl J Med doi: 10.1056/NEJMc1605684 – volume: 30 start-page: 4044 issue: 32 year: 2012 ident: 2406_CR9 publication-title: J Clin Oncol doi: 10.1200/JCO.2012.45.6541 – year: 2017 ident: 2406_CR13 publication-title: Ann Oncol doi: 10.1093/annonc/mdx684 – volume: 30 start-page: 1015 issue: 9 year: 2012 ident: 2406_CR15 publication-title: J Clin Oncol doi: 10.1200/JCO.2011.40.7098 – volume: 128 start-page: 4128 year: 2016 ident: 2406_CR44 publication-title: Blood doi: 10.1182/blood.V128.22.4128.4128 – volume: 7 start-page: 1122 issue: 8 year: 2011 ident: 2406_CR22 publication-title: Int J Biol Sci doi: 10.7150/ijbs.7.1122 – volume: 31 start-page: 469 issue: 2 year: 2013 ident: 2406_CR21 publication-title: Investig New Drugs doi: 10.1007/s10637-012-9889-4 – volume: 113 start-page: 3931 issue: 17 year: 2009 ident: 2406_CR3 publication-title: Blood doi: 10.1182/blood-2008-10-185256 – volume: 123 start-page: 2915 issue: 19 year: 2014 ident: 2406_CR42 publication-title: Blood doi: 10.1182/blood-2013-11-536359 – volume: 24 start-page: 612 issue: 4 year: 2006 ident: 2406_CR26 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.04.1384 – volume: 27 start-page: 5594 issue: 33 year: 2009 ident: 2406_CR8 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.23.8295 – volume: 129 start-page: 2437 issue: 17 year: 2017 ident: 2406_CR19 publication-title: Blood doi: 10.1182/blood-2016-12-756841 – volume: 87 start-page: 663 issue: 7 year: 2012 ident: 2406_CR37 publication-title: Am J Hematol doi: 10.1002/ajh.23213 – volume: 29 start-page: 4410 issue: 33 year: 2011 ident: 2406_CR11 publication-title: J Clin Oncol doi: 10.1200/JCO.2011.35.6287 – volume: 52 start-page: 1382 issue: 7 year: 2011 ident: 2406_CR16 publication-title: Leuk Lymphoma doi: 10.3109/10428194.2011.569038 – volume: 33 start-page: 942 issue: 4 year: 2015 ident: 2406_CR23 publication-title: Investig New Drugs doi: 10.1007/s10637-015-0258-y – volume: 35 start-page: 7549 issue: 15 suppl year: 2017 ident: 2406_CR36 publication-title: J Clin Oncol doi: 10.1200/JCO.2017.35.15_suppl.7549 – volume: 16 start-page: 86 issue: 6 year: 2013 ident: 2406_CR4 publication-title: J Hematol Oncol doi: 10.1186/1756-8722-6-86 – volume: 33 start-page: 140 issue: S1 year: 2015 ident: 2406_CR14 publication-title: Hematol Oncol – volume: 10 start-page: 1093 issue: 11 year: 2009 ident: 2406_CR1 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(09)70265-7 – volume: 27 start-page: 6027 issue: 35 year: 2009 ident: 2406_CR10 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.23.8592 – volume: 2 start-page: e66 issue: 2 year: 2015 ident: 2406_CR30 publication-title: Lancet Haematol. doi: 10.1016/S2352-3026(15)00002-2 – volume: 39 start-page: 1 issue: 1 year: 2015 ident: 2406_CR5 publication-title: Am J Surg Pathol doi: 10.1097/PAS.0000000000000312 – volume: 21 start-page: 1597 issue: 9 year: 2015 ident: 2406_CR18 publication-title: Biol Blood Marrow Transplant doi: 10.1016/j.bbmt.2015.05.003 – volume: 29 start-page: 1571 issue: 7 year: 2015 ident: 2406_CR27 publication-title: Leukemia doi: 10.1038/leu.2015.44 – volume: 30 start-page: 1311 issue: 6 year: 2016 ident: 2406_CR41 publication-title: Leukemia doi: 10.1038/leu.2016.13 – volume: 47 start-page: 1061 issue: 9 year: 2015 ident: 2406_CR33 publication-title: Nat Genet doi: 10.1038/ng.3358 – volume: 120 start-page: 2973 issue: 15 year: 2012 ident: 2406_CR12 publication-title: Blood doi: 10.1182/blood-2012-05-431460 – volume: 35 start-page: 1557 issue: 10 year: 2011 ident: 2406_CR38 publication-title: Am J Surg Pathol doi: 10.1097/PAS.0b013e318222dfcd – year: 2017 ident: 2406_CR43 publication-title: Haematologica doi: 10.3324/haematol.2017.180430 – volume: 27 start-page: 1688 issue: 8 year: 2013 ident: 2406_CR40 publication-title: Leukemia doi: 10.1038/leu.2013.41 – volume: 18 start-page: 4183 issue: 15 year: 2012 ident: 2406_CR29 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-1064 – volume: 10 start-page: 85 issue: 1 year: 2017 ident: 2406_CR7 publication-title: J Hematol Oncol doi: 10.1186/s13045-017-0452-9 – volume: 2 start-page: 591 issue: 7 year: 2012 ident: 2406_CR34 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-12-0028 – volume: 25 start-page: 555 issue: 3 year: 2011 ident: 2406_CR39 publication-title: Leukemia doi: 10.1038/leu.2010.295 – volume: 50 start-page: 254 issue: 4 year: 2015 ident: 2406_CR24 publication-title: Blood Res doi: 10.5045/br.2015.50.4.254 – volume: 17 start-page: 1240 issue: 9 year: 2016 ident: 2406_CR32 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(16)30148-6 – volume: 49 start-page: 902 issue: 7 year: 2014 ident: 2406_CR17 publication-title: Bone Marrow Transplant doi: 10.1038/bmt.2014.65 – volume: 2011 start-page: 790871 year: 2011 ident: 2406_CR31 publication-title: J Biomed Biotechnol doi: 10.1155/2011/790871 – volume: 57 start-page: 98 year: 2017 ident: 2406_CR6 publication-title: J Clin Exp Hematop doi: 10.3960/jslrt.17018 – volume: 50 start-page: 589 issue: 4 year: 2011 ident: 2406_CR20 publication-title: Acta Oncol doi: 10.3109/0284186X.2010.516272 |
SSID | ssj0017047 |
Score | 2.2252245 |
SecondaryResourceType | review_article |
Snippet | T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the... T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 413 |
SubjectTerms | Epidemiology Hematology International cooperation Intestine Lymphocytes T Lymphoma Medicine Medicine & Public Health Neoplasms Oncology Progress in Hematology T-cell lymphoma |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LSwMxEA5aQbyIb6tVInhSAt1HsrveiliK2p5a6G3ZPNZL3RW3Ffrvnck-qlQFz5lkl5kk802-mYSQa8kBh6bIqYfcZ-DxDJOAS5nWKhDG84LQMrrDkRhM_Mcpn1Z13EWd7V5TknanXhW7gTfCRLMQGQHBxCbZ4hi6wySeuL2GOgi69lWxbuRyxsF_1lTmT0N8d0ZrCHONHbVOp79Hdiu0SHuleffJhskOyPaw4sMPyXiUf5gZtcRz9lJQLBahAOloD2sj6fMSbJW_JhSzBZfUnjPd0TRXi4LmGR3TJNN09MTw9J7OKuHiiEz6D-P7AaveSWAKlDtnEFhqEygpQhNpYbhyHM3TNAkcXwJ6kDb1Bdp9PxUyCiFEiVyh0yTUPoRTKvCOSSvLM3NKqAMBih8ZFUrASSqJpDYa1qX2kNDkvmiTbq2wWFWXiONbFrN4df0x6jgGHceo4xi63DRd3sobNP4S7tRWiKvFVMSYY8gD3Fva5KpphmWA2kkyky9KGbx1OYAhTkrrNV8DRAN-OHTb5LY255fBf_uVs39Jn5MdF-eVzenpkNb8fWEuAK7M5aWdnp8Bo9yA priority: 102 providerName: Springer Nature |
Title | Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas |
URI | https://link.springer.com/article/10.1007/s12185-018-2406-6 https://www.ncbi.nlm.nih.gov/pubmed/29380182 https://www.proquest.com/docview/1993572578 https://www.proquest.com/docview/1993006976 |
Volume | 107 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdrAqUvZR9tl60rGvRpQyx2LMnuy_BGsrA0YYwEsidjfXgvqd3WySD_fe8UOdkIy5PBlmVzJ-l-p9_pjpBrxQGHFsipxzxiYPEsU4BLmTFaCtvrydgxuuOJGM6i73M-9xtutQ-rbNZEt1CbSuMe-ScMNOMSB9jn-weGVaOQXfUlNI5IG1OXYUiXnG8drkB2XYGxbhJyxsGUNqymOzoHtg3D1mLkFwQT_9qlPbC5R5Q6-zN4Tk49cKTpRtMvyDNbviTHY0-NvyLTSfXHLqjjoMvfNcVzIxTQHU3xmCS9XYPaqrucYuDgmrotpxtaVHpV06qkU5qXhk5GDDfy6cI3rs_IbNCffh0yXzKBaZDzkoGPaazUSsQ2McJyHQSGF0Uug0gBkFAuCgaeR1EhVBKDt5KEwhR5bCLwrLTsnZNWWZX2NaEB-CpRYnWsADLpPFHGGpiipofcJo9Eh3QbgWXa5xPHshaLbJcJGWWcgYwzlHEGr3zYvnK_SaZxqPFlo4XMz6s6242CDnm_fQwzAqWTl7ZabdpgAmYJXVxstLf9GoAbMMlx2CEfG3X-1fn_fuXN4V95S05CHEgunueStJaPK_sOoMpSXbnxeEXa6bdfoz5cv_QnP37C3VmYPgHN5-Qw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeJr7pNsBI8AKyaBPbSZAQGrCpo22EUCftLYs_spcuGaQd6j_F38idk3Sgib3t2Y5j3Z19v_Pv7AN4pSXi0II49VgKjh7PcY24lFtrIuXCMIo9oztN1ehIfD2Wxxvwu7sLQ2mV3Z7oN2pbGTojf0eJZjIiA_t4_oNT1ShiV7sSGo1ZjN3qF4Zs9YfDL6jf10FwsD_7POJtVQFucCoLjmGYdZHRKnaJVU6a4dDKosijodDoa7VPFMF2IQqlkxgBfRIoW-SxFRh8mCjEcW_BpggxlOnB5qf99Nv3NW8RDXxJs0ESSC7ReXc8qr-sh96UEuViYjQUV_96wivw9go16z3ewT3YaqEq22ts6z5suPIB3J62ZPxDmKXVhZszz3qXpzWjmyoM8STbo4uZbLJCQ6nOckapiivmD7nes6Iyy5pVJZuxvLQsHXOiDti87Vw_gqMbEedj6JVV6Z4CG2J0JBJnYo0gzeSJts7ipmBDYlOlUH0YdALLTPuCORXSmGeXby-TjDOUcUYyzvCTN-tPzpvnO67rvNtpIWtXcp1d2l0fXq6bcQ2SdPLSVcumDz35HOEQTxrtrf-GcApBQBz04W2nzr8G_99Utq-fygu4M5pNJ9nkMB3vwN2AjMpnE-1Cb_Fz6Z4hUFro5611Mji56QXxB4JsHgk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dTxQxEJ8gJMQXI6JyCloTfNE03H603SUhhogX4ODiw5Hc27r9WF6OXXTvNPev-dc50909MATeeG6320xnOr_pb9oB2NUCcWhBnHoiYo4ez3GNuJRba5R0UaQSz-iej-TxRXw6EZMV-NvdhaG0ym5P9Bu1rQydke9RoplQpGB7RZsW8f1o8OX6J6cKUsS0duU0GhUZusUfDN_qg5MjXOuPYTj4Nv56zNsKA9zgtGYcQzLrlNEycamVTpggsKIochXEGv2u9kkj2B7HhdRpguA-DaUt8sTGGIgYFeG4T2BNRSIgG1OTZbAXqL4vbtZPQ8EFuvGOUfXX9tCvUspcQtyG5PJ_n3gH6N4hab3vGzyHZy1oZYeNlm3AiitfwPp5S8tvwnhU_XZT5vnv8rJmdGeFIbJkh3RFk50tUGWqq5xR0uKC-eOufVZUZl6zqmRjlpeWjYacSAQ2bTvXL-HiUYT5ClbLqnRbwAKMk-LUmUQjXDN5qq2zuD3YiHhVEcse9DuBZaZ9y5xKakyzm1eYScYZyjgjGWf4yaflJ9fNQx4Pdd7uViFrbbrObjSwBx-WzWiNJJ28dNW86UOPPysc4nWzesu_IbBCOJCEPfjcLeetwe-bypuHp_Ie1tEMsrOT0fAtPA1Jp3xa0Taszn7N3Q4ippl-51WTwY_HtoV_D7kg2Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+findings+from+the+Asian+Lymphoma+Study+Group%3A+focus+on+T+and+NK-cell+lymphomas&rft.jtitle=International+journal+of+hematology&rft.au=Chan%2C+Jason+Yongsheng&rft.au=Lim%2C+Soon+Thye&rft.date=2018-04-01&rft.issn=1865-3774&rft.eissn=1865-3774&rft.volume=107&rft.issue=4&rft.spage=413&rft_id=info:doi/10.1007%2Fs12185-018-2406-6&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0925-5710&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0925-5710&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0925-5710&client=summon |